Mapaseka Seheri

Prof. Mapaseka Seheri


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2010 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
JMJason M. Mwenda
Jason M. Mwenda
KNKinkela Mina Ntoto
Kinkela Mina Ntoto
AAAlmaz Abebe
Almaz Abebe
CEChristabel Enweronu‐Laryea
Christabel Enweronu‐Laryea
IAIsmail Amina
Ismail Amina
DSDuncan Steele
Duncan Steele
Severe rotavirus diarrhea in children <5 years of age is a major public health problem; however, limited regional and country specific data on rot

1 November 2014 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
MGMichelle J Groome
Michelle J Groome
NPNicola Page
Nicola Page
MCMargaret M Cortese
Margaret M Cortese
JMJocelyn Moyes
Jocelyn Moyes
HZHeather J Zar
Heather J Zar
SMShabir A Madhi
Shabir A Madhi

21 June 2017 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
DODarwin J Operario
Darwin J Operario
JPJames A Platts-Mills
James A Platts-Mills
SNSandrama Nadan
Sandrama Nadan
NPNicola Page
Nicola Page
MSMapaseka Seheri
Mapaseka Seheri
EHEric R Houpt
Eric R Houpt
The etiology of acute watery diarrhea remains poorly characterized, particularly after rotavirus vaccine introduction. We performed quantitative polymerase chain reaction for multiple enteropathogens on 878 acute watery diarrheal stools sampled from 14643 episodes captured by surveillance of children <5 years of age during 2013–2014 from 16 countries. We used previously developed models of the association between pathogen quantity and diarrhea to calculate pathogen-specific weighted attributable fractions (AFs). Rotavirus remained the leading etiology (overall weighted AF, 40.3% [95% confidence interval {CI}, 37.6%–44.3%]), though the AF was substantially lower in the Americas (AF, 12.2 [95% CI, 8.9–15.6]), based on samples from a country with universal rotavirus vaccination. Norovirus GII (AF, 6.2 [95% CI, 2.8–9.2]), Cryptosporidium (AF, 5.8 [95% CI, 4.0–7.6]), Shigella (AF, 4.7 [95% CI, 2.8–6.9]), heat-stable enterotoxin-producing Escherichia coli (ST-ETEC) (AF, 4.2 [95% CI, 2.0–6.1]), and adenovirus 40/41 (AF, 4.2 [95% CI, 2.9–5.5]) were also important. In the Africa Region, the rotavirus AF declined from 54.8% (95% CI, 48.3%–61.5%) in rotavirus vaccine age-ineligible children to 20.0% (95% CI, 12.4%–30.4%) in age-eligible children. Rotavirus remained the leading etiology of acute watery diarrhea despite a clear impact of rotavirus vaccine introduction. Norovirus GII, Cryptosporidium, Shigella, ST-ETEC, and adenovirus 40/41 were also important. Prospective surveillance can help identify priorities for further reducing the burden of diarrhea.

1 December 2013 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
VEERLE DERMAUX MSIMANGVEERLE DERMAUX MSIMANG
VEERLE DERMAUX MSIMANG
NPNicola Page
Nicola Page
MGMichelle J. Md Groome
Michelle J. Md Groome
JMJocelyn Md Moyes
Jocelyn Md Moyes
MCMargaret M. Cortese
Margaret M. Cortese
CCCheryl Cohen
Cheryl Cohen
Background: Oral rotavirus vaccine was introduced into the South African routine immunization program in August 2009 administered at 6 and 14 weeks with no catch-up. We described the change in rotavirus-associated diarrheal hospitalizations among children <5 years at 3 sentinel sites from 2009 through 2011. Methods: During 2009 through 2011, we compared the proportion of enrolled children aged <5 years hospitalized with acute gastroenteritis and testing rotavirus positive. We used hospital data to determine the change in diarrhea hospitalizations and estimated total numbers of rotavirus hospitalizations by adjusting for nonenrolled patients. Stool samples were tested for rotavirus using enzyme immunoassay. Results: In 2009 (May–December), 46% (404/883) of samples among children <5 years tested rotavirus positive, decreasing to 33% (192/580) (P < 0.001) in 2010 and 29% (113/396) (P < 0.001) in 2011. Compared with May–December 2009, total diarrhea hospitalizations among children aged <5 years was one-third lower in May–December of 2010 and 2011. Among infants, adjusted rotavirus hospitalizations were 61% (n = 267) and 69% (n = 214) lower, respectively, in 2010 and 2011 when compared with 2009 (n = 689), and 45 and 50 percentage points greater than the reduction in rotavirus-negative cases. Among children <5 years, rotavirus hospitalizations were 54% and 58% lower in 2010 and 2011, compared with 2009 (40 and 44 percentage points greater than reduction in rotavirus-negative cases). Rotavirus reductions occurred in rural and urban settings. Conclusion: Using published estimates of rotavirus hospitalization burden, we estimate that at least 13,000 to 20,000 hospitalizations in children <2 years were prevented in the 2 years after rotavirus vaccine introduction.

1 November 2018 in Vaccine
Verified
Journal Article
Closed access
MSMapaseka Seheri
Mapaseka Seheri
NMN.B. Magagula
N.B. Magagula
IPI. Peenze
I. Peenze
KRK. Rakau
K. Rakau
ANA. Ndadza
A. Ndadza
MMM.J. Mphahlele
M.J. Mphahlele